Lombard Odier Asset Management (USA)’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-101,966	Closed	-$1.33M	–	260
2016 Q3	$1.33M	Sell	101,966 -98,034	-49%	-$1.3M	0.12%	179
2016 Q2	$2.78M	Buy	200,000 +110,469	+123%	+$1.63M	0.34%	85
2016 Q1	$1.36M	Sell	89,531 -51,836	-37%	-$793K	0.18%	119
2015 Q4	$2.68M	Buy	141,367 +5,657	+4%	+$108K	0.26%	112
2015 Q3	$2.58M	Sell	135,710 -4,290	-3%	-$107K	0.23%	129
2015 Q2	$3.61M	Buy	+140,000	New	+$3.97M	0.26%	129

Other funds holding PRTK

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s PRTK Position: Q4 2016 in Review

Lombard Odier Asset Management (USA) sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2016, closing a stake of 101,966 shares — an estimated $1.33M sold.

Lombard Odier Asset Management (USA) first reported a position in PRTK in Q2 2015 and held it in 6 quarters. The position peaked at $3.61M in Q2 2015. 92 funds tracked by Wall St. Rank hold PRTK as of Q4 2016.

Lombard Odier Asset Management (USA) reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 101,966 Paratek Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1.33M.
Lombard Odier Asset Management (USA) first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2015 and held it in 6 quarters.
Lombard Odier Asset Management (USA)'s Paratek Pharmaceuticals, Inc. position peaked at $3.61M in Q2 2015.
92 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2016.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2016, filed 15 Feb 2017.